Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
Pourquoi ce travail est-il dans la base ?
Une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée. Voici les voies qui ont admis celui-ci.
Aucune affiliation canadienne. Une base fondée sur la seule affiliation (le devis habituel) n'aurait jamais vu ce travail. C'est l'un des travaux qui justifient l'inversion de la base.
Résumé
BACKGROUND: Overweight and obesity is a global epidemic. Forecasting future trajectories of the epidemic is crucial for providing an evidence base for policy change. In this study, we examine the historical trends of the global, regional, and national prevalence of adult overweight and obesity from 1990 to 2021 and forecast the future trajectories to 2050. METHODS: Leveraging established methodology from the Global Burden of Diseases, Injuries, and Risk Factors Study, we estimated the prevalence of overweight and obesity among individuals aged 25 years and older by age and sex for 204 countries and territories from 1990 to 2050. Retrospective and current prevalence trends were derived based on both self-reported and measured anthropometric data extracted from 1350 unique sources, which include survey microdata and reports, as well as published literature. Specific adjustment was applied to correct for self-report bias. Spatiotemporal Gaussian process regression models were used to synthesise data, leveraging both spatial and temporal correlation in epidemiological trends, to optimise the comparability of results across time and geographies. To generate forecast estimates, we used forecasts of the Socio-demographic Index and temporal correlation patterns presented as annualised rate of change to inform future trajectories. We considered a reference scenario assuming the continuation of historical trends. FINDINGS: Rates of overweight and obesity increased at the global and regional levels, and in all nations, between 1990 and 2021. In 2021, an estimated 1·00 billion (95% uncertainty interval [UI] 0·989-1·01) adult males and 1·11 billion (1·10-1·12) adult females had overweight and obesity. China had the largest population of adults with overweight and obesity (402 million [397-407] individuals), followed by India (180 million [167-194]) and the USA (172 million [169-174]). The highest age-standardised prevalence of overweight and obesity was observed in countries in Oceania and north Africa and the Middle East, with many of these countries reporting prevalence of more than 80% in adults. Compared with 1990, the global prevalence of obesity had increased by 155·1% (149·8-160·3) in males and 104·9% (95% UI 100·9-108·8) in females. The most rapid rise in obesity prevalence was observed in the north Africa and the Middle East super-region, where age-standardised prevalence rates in males more than tripled and in females more than doubled. Assuming the continuation of historical trends, by 2050, we forecast that the total number of adults living with overweight and obesity will reach 3·80 billion (95% UI 3·39-4·04), over half of the likely global adult population at that time. While China, India, and the USA will continue to constitute a large proportion of the global population with overweight and obesity, the number in the sub-Saharan Africa super-region is forecasted to increase by 254·8% (234·4-269·5). In Nigeria specifically, the number of adults with overweight and obesity is forecasted to rise to 141 million (121-162) by 2050, making it the country with the fourth-largest population with overweight and obesity. INTERPRETATION: No country to date has successfully curbed the rising rates of adult overweight and obesity. Without immediate and effective intervention, overweight and obesity will continue to increase globally. Particularly in Asia and Africa, driven by growing populations, the number of individuals with overweight and obesity is forecast to rise substantially. These regions will face a considerable increase in obesity-related disease burden. Merely acknowledging obesity as a global health issue would be negligent on the part of global health and public health practitioners; more aggressive and targeted measures are required to address this crisis, as obesity is one of the foremost avertible risks to health now and in the future and poses an unparalleled threat of premature disease and death at local, national, and global levels. FUNDING: Bill & Melinda Gates Foundation.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
La notice
- Revue
- The Lancet
- Thématique
- Obesity, Physical Activity, Diet
- Domaine
- Medicine
- Établissements canadiens
- —
- Organismes subventionnaires
- CilagDaiichi Sankyo EuropeDSM Nutritional ProductsJapan Science and Technology AgencyNational Health and Medical Research CouncilMedical Research CouncilNovartis PharmaAllerganNational Institutes of HealthTour de CureAlberta Health ServicesGovernment of AlbertaSwedish Orphan BiovitrumLaboratório Associado para a Química VerdeNational Cerebral and Cardiovascular CenterRede de Química e TecnologiaH. Lundbeck A/SSanofiNational Office for Philosophy and Social SciencesLilly DeutschlandAgència de Gestió d'Ajuts Universitaris i de RecercaNational Research FoundationNational Institute for Health and Care ResearchVlaamse regeringSanofi GenzymeNovo NordiskUniversidade do PortoFonds Wetenschappelijk OnderzoekHospital Research FoundationMinistry of EducationFondazione CariploUniversity of AlbertaGeneralitat de CatalunyaMinistry of Education, Culture, Sports, Science and TechnologyGovernment of CanadaNational Heart, Lung, and Blood InstituteChinese Nutrition SocietyNational Institute on Minority Health and Health DisparitiesAstraZenecaJohns Hopkins UniversityAmarin CorporationPrecursory Research for Embryonic Science and TechnologyWorld Health OrganizationNovo Nordisk PharmaMinistério da Ciência, Tecnologia e Ensino SuperiorWellcome TrustNational Research Foundation of KoreaKing Saud UniversityDepartment of Health and Social CareInternational Headache SocietyDanoneNational Science and Technology CouncilAmerican Heart AssociationGuangdong Provincial Hospital of Traditional Chinese MedicineMinistarstvo Prosvete, Nauke i Tehnološkog RazvojaCardiff UniversityEli Lilly and CompanyU.S. Department of DefenseCanadian Institutes of Health ResearchKorean Diabetes AssociationAmerican Diabetes AssociationFundação para a Ciência e a TecnologiaBill and Melinda Gates FoundationAmgen
- Mots-clés
- OverweightObesityEnvironmental healthMedicineBurden of diseaseDiseaseGlobal healthDemographyPublic healthInternal medicinePopulationPathology
- Résumé présent dans OpenAlex
- oui